雅思阅读考试难度变化分析
自雅思考试问世以来，难度呈逐年递加趋势，下面小编给大家带来了雅思阅读考试难度变化分析，希望能够帮助到大家，下面小编就和大家分享，来欣赏一下吧。
雅思阅读考试难度变化分析
雅思学术类考试中，阅读单项以科普类、人文类文章为主，主要考察考生三方面能力：基础能力、做题方法、定位能力。
首先，基础能力变难的方向是同义替换难度加大，整体的单词范围和长难句考察范围难度变化不大。在剑4年代，同义词考察基本是operate对应work这种两个词都应该认识的简单对应，而现在很有可能会出现原文和题干只认识一个词的情况，同义替换的考察难度有所升级。
其次，就做题方法而言，只要题型没有发生变化，那么新东方雅思课上讲过的应对方法依然是有效的，无效的是那些蒙题的方法。早年的雅思，不乏学生单词量平平，但是经过学习技巧，获得了高于自己水平的分数，这种情况在现在已经基本不会有了。譬如说，早年判断题选择true的机率是最大的，而在剑10当中，那些带绝对词可以蒙的题已经几乎绝迹，而true的比例也不如过去那么大。
最后，定位是难度增加幅度最大的。现在越来越多词没有明显的定位词，这加大了考生寻找的难度，需要考生扫读文章，甚至定位词本身在原文当中就发生了同义词替换。此外，逆序和题目跨度大这两种情况频发，逆序是指比如第一题在第三段，正常来讲第二题应该从第一题原文位置之后寻找，而第二题其实出现在了第三段之前;题目跨度大是指第一题和第二题在原文当中间隔太长。这两种情况对于考生来说，都是找不到答案所在之处的绊脚石。
对于越来越难的雅思考试，新东方雅思项目的各位老师给同学们提出了以下备考建议：
雅思阅读--1、 背单词是基础
对于考生而言，得阅读者得天下。读文章的时候有生词是正常的，专有名词不是大家需要重点关注的词汇，而真正需要大家重点关注的、经常被替换的同义词，会不止一次的出现在真题中，所以多背单词、多总结真题当中的同义词是以不变应万变的万全之策。
雅思阅读--2、 掌握配对题的应对方法
匹配题是雅思阅读考试重点题型之一，一般当文章正文标注了ABCD段落的时候，可能会考到段落小标题或段落信息题中的一种，段落小标题侧重于各段的总结归纳，段落信息匹配则侧重细节考察和信息筛选。解答此类题目，首先要关注是否有’more than once’这样的提示，然后读一下每道题目的句子，大致判断其在文中的位置、各题目大致排序，然后到目标段落定位关键词。解答这类题目时有一个细节性规律：如果某道题描述带有明显的background、history这种提示词，则重点去文章第一二段定位答案，此两段重点描述写作背景;如果题目描述中带有比较明显的预测、未来、推广等含义，则重点去末尾两段定位，此两段主要是对整篇文章的总结和对未来的展望。综上，段落信息匹配题的答题关键是读清题干，把握住题干所阐述内容属于文章前中后什么位置，抓住核心词，去目标段落寻找其同义替换。掌握了这一规律和思路，多加练习，那么便能更好的掌握段落信息匹配题的解题要领。
雅思阅读--3、 找对方法，切忌盲目跟风
虽然说雅思阅读逐渐变难，但是只要考生从本质上提高自己的基础、找准学习方法、找对老师，依然可以高效突破雅思考试。尤其是要有针对性有选择性的学习适合自己的做题方法，切忌不可盲从网上流传的早已失效的各种做题方法。
希望大家都可以早日和雅思阅读分手，漂洋过海去看那片属于你的蓝天。
雅思阅读全真模考题:大气变化
Changes in Air
A
A federal ban on ozone-depleting chlorofluorocarbons (CFCs), to conform with the Clean Air Act, is, ironically, affecting 22.9 million people in the U.S. who suffer from asthma, Genetic inhaled albuterol, which is the most commonly prescribed short-acting asthma medication and requires CFCs to propel it into the lungs, will no longer be legally sold after December 31, 2008. Physicians and patients are questioning the wisdom of the ban, which will have an insignificant effect on ozone but a measurable impact on wallets: the reformulated brand-name alternatives can be three times as expensive, raising the cost to about $40 per inhaler. The issue is even more disconcerting considering that asthma disproportionately affects the poor and that according to recent surveys, an estimated 20 percent of asthma patients are uninsured.
B
"The decision to make the change was political, not medical or scientific," says pharmacist Leslie Hendeles of the University of Florida, who co-authored a 2007 paper in the New England Journal of Medicine explaining the withdrawal and transition. In 1987 Congress signed on to the Montreal Protocol on Substances That Deplete the Ozone Layer, an international treaty requiring the phasing out of all nonessential uses of CFCs. At that time, medical inhalers were considered an essential use because no viable alternative propellant existed. In 1989 pharmaceutical companies banded together and eventually, in 1996, reformulated albuterol with hydrofluoroalkane.
C
The transition began quietly, but as more patients see their prescriptions change and costs go up, many question why this bail must begin before generics become available. At least one member of the FDA advisory committee, Nicholas J. Gross of the Stritch-Loyola School of Medicine, has publicly regretted the decision, recanting his support and requesting that the ban be pushed back until 2010, when the first patent expires.
D
Gross notes that the decision had nothing to do with the environment Albuterol inhalers contributed less than 0.1 percent of the CFCs released when the treaty was signed. "Lt's a symbolic issue" Gross remarks. Some skeptics instead point to the billions of dollars to be gained by the three companies holding the patents on the available HFA-albuterol inhalers, namely Glaxo-SmithKline, Schering-Plough and Teva. Although the FDA advisory committee recognized that the expenses would go up, Hendeles says, it also believed that the companies would help defray the added costs for individuals, Firms, for instance, had committed to donating a million HFA inhalers to clinics around the country. According to Hendeles, GlaxoSmithKline did not follow through, although Schering-Plough and Teva did. GlaxoSmithKline did not respond to requests for comment.
E
The issue now, Hendeles says, is that pharmaceutical-grade CFCs are in short supply, and the public faces the risk of a shortage of albuterol inhalers if the FDA does not continue promoting the production of HFA inhalers. He posits that even costs of generics would go up as CFCs become scarcer. Gross disagrees, saying that the inhaler shortage and the closure of CFC manufacturing plants are a result of the ban.
F
The HFA inhalers also have encountered resistance because some asthmatics insist that they do not work as well as the CFC variety. But, Hendeles says, the differences are in the mechanics and maintenance—unlike CFC inhalers, the HFA versions must be primed more diligently and rinsed to accommodate the stickier HFA formulation. They also run out suddenly without the warning with a CFC inhaler, that the device is running low. "Pharmacists may not tell people of these things, and the doctors don't know," Hendeles says.
G
The main public health issue in this decision may be the side effects of the economics, not the drug chemistry. Multiple studies have shown that raising costs leads to poorer adherence to treatment. One study discovered that patients took 30 percent less amtiasthma medication when their co-pay doubled. In the ease of a chronic disease such as asthma, it is particularly difficult to get people to follow regular treatment plans. "Generally speaking, for any reason you don’t take medication, cost makes it more likely” that you do not, comments Michael Chernew, a health policy expert at Harvard Medical School.
H
Such choices to forgo medication could affect more than just the patients themselves. "For example," Hendeles points out, "in a pregnant mother with untreated asthma, less oxygen is delivered to the fetus, which can lead to congenital problems and premature birth." And considering that the disease disproportionately strikes the poor, what seemed to be a good, responsible environmental decision might in the end exact an unexpected human toll.
Question 14-18
Use the information in the passage to match the people (listed A-C) with opinions or deeds below. Write the appropriate letters A-C in boxes 14-18 on your answer sheet.
NB you may use any letter more than once
A Nicholas J. Gross
B Michael Chernew
C Leslie Hendeles
14. Put forward that the increase in the price of drugs would contribute to the patients' negative decision on the treatment.
15. Spoke out a secret that the druggists try to hold back.
16. Pointed out that the protocol itself is not concerning the environment.
17. Demonstrated that the stop of providing alternatives for CFCs would worsen rather than help with the situation.
18. In public repented of his previous backing up of the prohibition proposal.
Question 19-22
Do the following statements agree with the information given in Reading Passage?
In boxes 19-22 on your answer sheet, write
TRUE if the statement is true
FALSE if the statement is false
NOT GIVEN if the information is not given in the passage
19. It took almost a decade before the replacement drug for the asthma therapy was ultimately developed by the joint effort of several drug companies.
20. One of the FDA committee members had a decisive impact on the implement of the ban on chlorofluorocarbons.
21. As a matter of fact, the emitted chlorofluorocarbons in asthma treatment took up quite an insignificant amount at the time when the pact was reached.
22. The HFA and CFC inhalers have something different regarding the therapeutic effect.
Question 23-27
Complete the following summary of the paragraphs of Reading Passage, using No More than Three words from the Reading Passage for each answer. Write your answers in boxes 23-27 on your answer sheet.
American people with asthma would be impacted by...23...about chlorofluorocarbons which would consume the ozone layer. The usually used...24...would be considered illegal because it needs the propelment of...25.... The...26...would cost the patients considerably more money. Impoverished people are far more likely to Suffer from asthma and what makes it even worse is that some of them are in...27...condition.
雅思阅读考试难度变化分析相关文章：
★ 雅思阅读解题技巧
雅思阅读考试难度变化分析
上一篇：雅思阅读长难句翻译练习
